Clinical trials recruiting for Mild Cognitive Impairment Due to Alzheimer's Disease
3
Recruiting trials
1
US states with sites
3
Countries
33%
Accept healthy volunteers
Phase breakdown
Phase 2 1Phase 3 1Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Atomoxetine | 1 |
| Foralumab TZLS-401 100 µg | 1 |
| Foralumab TZLS-401 50 µg | 1 |
| Metformin 1000 mg Oral Tablet | 1 |
| Spermidine Supplementation | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Massachusetts | 1 |
Top cities
Self-screener
Recruiting trials
- An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease
- Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
- Autophagy-Enhancers to Reduce Sleep Disturbances
Related conditions
Trials recruiting for Mild Cognitive Impairment Due to Alzheimer's Disease often also study these conditions. Each links to its own recruiting-trial list.
Alzheimer's disease 617Subjective Cognitive Decline (SCD) 13Dementia 106Alzheimer's Disease (AD) 5
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Mild Cognitive Impairment Due to Alzheimer's Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.